KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BEAT
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

BioTelemetry stock downgraded from Hold/Accumulate to Sell Candidate after Friday trading session.
(Updated on Apr 26, 2024)

Sell candidate since Apr 26, 2024 PDF

The BioTelemetry stock price gained 1.73% on the last trading day (Friday, 26th Apr 2024), rising from $1.97 to $2.00. During the last trading day the stock fluctuated 4.06% from a day low at $1.97 to a day high of $2.05. The price has been going up and down for this period, and there has been a 2.56% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 571 more shares were traded than the day before. In total, 23 thousand shares were bought and sold for approximately $46.17 thousand.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 19.93% during the next 3 months and, with a 90% probability hold a price between $2.02 and $3.13 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BEAT Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). BioTelemetry has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. The BioTelemetry stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.01 and $2.13. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, April 17, 2024, and so far it has fallen -7.41%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for BioTelemetry stock

BioTelemetry finds support from accumulated volume at $1.99 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0800 between high and low, or 4.06%. For the last week, the stock has had daily average volatility of 5.58%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BEAT) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect BioTelemetry to open at $2.01, and during the day (based on 14 day Average True Range), to move between $1.84 and $2.16, which gives a possible trading interval of +/-$0.161 (+/-8.05%) up or down from last closing price. If BioTelemetry takes out the full calculated possible swing range there will be an estimated 16.10% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.99 (0.50%) than the resistance at $2.05 (2.50%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is BioTelemetry stock A Buy?

The BioTelemetry stock holds several negative signals and despite the positive trend, we believe BioTelemetry will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -4.483 Sell Candidate Downgraded

Predicted Opening Price for BioTelemetry of Monday, April 29, 2024

Fair opening price April 29, 2024 Current price
$2.01 ( 0.333%) $2.00

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BEAT

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.09 4.33 %
R2 2.06 2.81 %
R1 2.04 1.86 %
Current price: 2.00
Support S1 1.98 -1.19 %
S2 1.96 -2.14 %
S3 1.93 -3.67 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.32 16.00 %
R2 2.14 7.00 %
R1 2.05 2.50 %
Current price 2.00
Support S1 1.99 -0.500%
S2 1.80 -10.00%
S3 1.59 -20.50%

FAQ

What is the symbol for BioTelemetry Stock and on which exchange is it traded?
The symbol for BioTelemetry is BEAT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell BioTelemetry Stock?
The BioTelemetry stock holds several negative signals and despite the positive trend, we believe BioTelemetry will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy BioTelemetry Stock?
BioTelemetry Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy BioTelemetry Stock.

What's the current price of BioTelemetry Stock?
As of the end of day on the Apr 26, 2024, the price of an BioTelemetry (BEAT) share was $2.00.

What is the 52-week high and low for BioTelemetry Stock?
The 52-week high for BioTelemetry Stock is $3.74 and the 52-week low is $1.06.

What is the market capitalization of BioTelemetry Stock?
As of the Apr 26, 2024, the market capitalization of BioTelemetry is 52.658M.

When is the next earnings date for BioTelemetry?
The upcoming earnings date for BioTelemetry is May 09, 2024.
Click to get the best stock tips daily for free!

About BioTelemetry

BioTelemetry HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the... BEAT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT